SAN ANTONIO — We're approaching three years since COVID-19 reared its ugly head to the world, and we're getting used to living with it. But COVID numbers are once again on the way up. We are in the ...
A dwindling COVID-19 vaccine market is not stopping Arcturus Therapeutics from pressing ahead with its own mRNA candidate, as the biotech touts new early data indicating its shot lights up the immune ...
Some recent data suggest that, for now, COVID-19 may be a year-round problem, driven more by human behavior and immunity levels than weather patterns. Credit: Unsplash / Maxime The pandemic may no ...
Millions of Americans report having long COVID, either previously or at the time of being surveyed, according to new data from the the Centers for Disease Control and Prevention's National Center for ...
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)-- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis ...
With COVID levels high across most of the country, some people may find themselves experiencing symptoms of COVID rebound in the coming weeks. “COVID rebound is a recurrence of COVID symptoms after ...
SAN ANTONIO — People battling long COVID have suffered for months and years, often with debilitating symptoms. In this Healthy SA, we learn how experts are finally defining the condition after four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results